These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 15993820)

  • 1. Effects of N-methyl-D-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice.
    Fischer BD; Carrigan KA; Dykstra LA
    J Pain; 2005 Jul; 6(7):425-33. PubMed ID: 15993820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential antinociception by morphine and methadone in two sub-strains of Sprague-Dawley rats and its potentiation by dextromethorphan.
    Bulka A; Wiesenfeld-Hallin Z; Xu XJ
    Brain Res; 2002 Jun; 942(1-2):95-100. PubMed ID: 12031857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
    Allen RM; Dykstra LA
    J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antinociceptive effect of combined systemic administration of morphine and the glycine/NMDA receptor antagonist, (+)-HA966 in a rat model of peripheral neuropathy.
    Christensen D; Idänpään-Heikkilä JJ; Guilbaud G; Kayser V
    Br J Pharmacol; 1998 Dec; 125(8):1641-50. PubMed ID: 9886755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
    Lutfy K; Doan P; Weber E
    Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid antinociception, tolerance and dependence: interactions with the N-methyl-D-aspartate system in mice.
    Dykstra LA; Fischer BD; Balter RE; Henry FE; Schmidt KT; Miller LL
    Behav Pharmacol; 2011 Sep; 22(5-6):540-7. PubMed ID: 21712708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat.
    Redwine KE; Trujillo KA
    Pharmacol Biochem Behav; 2003 Sep; 76(2):361-72. PubMed ID: 14592689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).
    Fischer BD; Miller LL; Henry FE; Picker MJ; Dykstra LA
    Psychopharmacology (Berl); 2008 Jun; 198(2):271-8. PubMed ID: 18392754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the polyamine site of NMDA receptors produces antinociception and enhances the effect of morphine, in mice.
    Bernardi M; Bertolini A; Szczawinska K; Genedani S
    Eur J Pharmacol; 1996 Feb; 298(1):51-5. PubMed ID: 8867919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
    Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
    Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
    Baker AK; Hoffmann VL; Meert TF
    Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of morphine analgesia by site-specific N-methyl-D-aspartate receptor antagonists: dependence on sex, site of antagonism, morphine dose, and time.
    Nemmani KVS; Grisel JE; Stowe JR; Smith-Carliss R; Mogil JS
    Pain; 2004 Jun; 109(3):274-283. PubMed ID: 15157688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of glutamatergic receptors in the nucleus cuneiformis in modulating morphine-induced antinociception in rats.
    Haghparast A; Gheitasi IP; Lashgari R
    Eur J Pain; 2007 Nov; 11(8):855-62. PubMed ID: 17291798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA antagonist modulation of morphine antinociception in female vs. male rats.
    Craft RM; Lee DA
    Pharmacol Biochem Behav; 2005 Apr; 80(4):639-49. PubMed ID: 15820534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors.
    Wong CS; Cherng CH; Luk HN; Ho ST; Tung CS
    Eur J Pharmacol; 1996 Feb; 297(1-2):27-33. PubMed ID: 8851162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects.
    Fischer BD; Ward SJ; Henry FE; Dykstra LA
    Neuropharmacology; 2010 Feb; 58(2):544-50. PubMed ID: 19699755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
    Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
    Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the N-methyl-d-aspartate receptor unmasks the antinociception of endogenous opioids in the periphery.
    Zhang GH; Min SS; Seol GH; Lee KS; Han H; In Kim Y; Han HC
    Pain; 2009 Jun; 143(3):233-237. PubMed ID: 19361925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor.
    Allen RM; Granger AL; Dykstra LA
    J Pharmacol Exp Ther; 2003 Nov; 307(2):785-92. PubMed ID: 12975489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.